We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
+$32.4M
Cap. Flow
+$22.9M
Cap. Flow %
10.08%
Top 10 Hldgs %
34.54%
Holding
251
New
51
Increased
110
Reduced
51
Closed
28

Sector Composition

Rank Sector Weight
1 Healthcare 9.45%
2 Technology 8.15%
3 Consumer Discretionary 7.84%
4 Financials 7.34%
5 Energy 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AON icon
226
Aon
AON
$77.3B
-751
Closed -$242K
ARCT icon
227
Arcturus Therapeutics
ARCT
$157M
-16,857
Closed -$130K
BKLC icon
228
BNY Mellon US Large Cap Core Equity ETF
BKLC
$1.79B
-6,618
Closed -$275K
CAT icon
229
Caterpillar
CAT
$409B
-454
Closed -$322K
CMI icon
230
Cummins
CMI
$91.7B
-929
Closed -$500K
CVE icon
231
Cenovus Energy
CVE
$54.6B
-10,000
Closed -$265K
DVN icon
232
Devon Energy
DVN
$51.9B
-4,050
Closed -$204K
FDVV icon
233
Fidelity High Dividend ETF
FDVV
$10.1B
-53,925
Closed -$2.98M
GEHC icon
234
GE HealthCare
GEHC
$27.6B
-3,007
Closed -$214K
IBN icon
235
ICICI Bank
IBN
$106B
-9,017
Closed -$234K
MDT icon
236
Medtronic
MDT
$107B
-4,089
Closed -$354K
OPRT icon
237
Oportun Financial
OPRT
$257M
-22,093
Closed -$102K
PLTR icon
238
Palantir
PLTR
$295B
-1,685
Closed -$246K
ROST icon
239
Ross Stores
ROST
$76.6B
-2,752
Closed -$596K
RTO icon
240
Rentokil
RTO
$14.3B
-6,665
Closed -$210K
RVPH
241
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
-15,694
Closed -$11.5K
SGOL icon
242
abrdn Physical Gold Shares ETF
SGOL
$6.92B
-9,147
Closed -$408K
SIVR icon
243
abrdn Physical Silver Shares ETF
SIVR
$4.04B
-22,781
Closed -$1.63M
TIGR
244
UP Fintech Holding
TIGR
$845M
-11,753
Closed -$74K
TJX icon
245
TJX Companies
TJX
$170B
-1,848
Closed -$295K
TNYA icon
246
Tenaya Therapeutics
TNYA
$168M
-153,137
Closed -$106K
UBER icon
247
Uber
UBER
$134B
-2,970
Closed -$214K
URI icon
248
United Rentals
URI
$71.1B
-293
Closed -$213K
VUG icon
249
Vanguard Growth ETF
VUG
$216B
-8,670
Closed -$631K
ZTS icon
250
Zoetis
ZTS
$31.6B
-3,098
Closed -$366K

Similar funds

Castleview Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Castleview Partners held 251 positions worth $228M, up 17% from $195M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Castleview Partners deployed $22.9M of net new capital in Q2 2026, opening 51 new positions and adding to 110 existing holdings. Its largest new stake was Nomura Tax-Free USA Short Term ETF: 223,409 shares worth $5.68M.

By sector, the portfolio is most concentrated in Healthcare at 9.5% of assets, up from 8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Fidelity Enhanced Large Cap Growth ETF, an estimated $2M trimmed.

  • Castleview Partners's largest Q2 2026 buy was Nomura Tax-Free USA Short Term ETF: 223,409 shares worth $5.68M.
  • Castleview Partners added most to Tesla in Q2 2026, an estimated $1.66M increase.
  • Castleview Partners's biggest Q2 2026 reduction was Fidelity Enhanced Large Cap Growth ETF, cutting an estimated $2M.
  • Castleview Partners fully exited Fidelity High Dividend ETF in Q2 2026, selling an estimated $2.98M.
  • Castleview Partners's ten largest holdings make up 35% of its $228M portfolio in Q2 2026.
  • Castleview Partners opened 51 new positions and closed 28 in Q2 2026.
  • Castleview Partners's portfolio value rose 17% quarter-over-quarter to $228M.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.